AbbVie Inc
(LTS:0QCV)
$
202.39
0.335 (0.17%)
Market Cap: 352.54 Bil
Enterprise Value: 416.34 Bil
PE Ratio: 69.27
PB Ratio: 58.44
GF Score: 87/100 
Abbvie Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 26, 2021 / 03:40PM GMT
Release Date Price:
$89.45
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst
Good morning, everybody. Welcome to our next session at our Global Healthcare Virtual conference. I'm delighted to welcome AbbVie to the GHC this year. AbbVie is represented by Mike Severino, Vice Chairman and President; Rob Michael, EVP and Chief Financial Officer; and Jeff Stewart, EVP of Commercial Operations. Liz Shea will be standing by to keep us all within bounds. So thank you all for joining us this morning.
Michael E. Severino
AbbVie Inc. - Vice Chairman & President
It's a pleasure to be here. Good to see you, Geoff.
Questions & Answers
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst
So Mike, perhaps the most pressing question that I hear from investors is about RINVOQ and safety and all that sort of thing. So perhaps you could give us your
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers